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IMPORTANCE Self-testing for HIV infectionmay contribute to early diagnosis of HIV, but
without necessarily increasing antiretroviral therapy (ART) initiation.
OBJECTIVE To investigate whether offering optional home initiation of HIV care after HIV
self-testing might increase demand for ART initiation, compared with HIV self-testing
accompanied by facility-based services only.
DESIGN, SETTING, AND PARTICIPANTS Cluster randomized trial conducted in Blantyre, Malawi,
between January 30 and November 5, 2012, using restricted 1:1 randomization of 14
community health worker catchment areas. Participants were all adult (16 years) residents
(n = 16 660) who received access to home HIV self-testing through resident volunteers. This
was a second-stage randomization of clusters allocated to the HIV self-testing group of a
parent trial.
INTERVENTIONS Clusters were randomly allocated to facility-based care or optional home
initiation of HIV care (including 2 weeks of ART if eligible) for participants reporting positive
HIV self-test results.
MAIN OUTCOMES ANDMEASURES The preplanned primary outcome compared between
groups the proportion of all adult residents who initiated ARTwithin the first 6months of HIV
self-testing availability. Secondary outcomes were uptake of HIV self-testing, reporting of
positive HIV self-test results, and rates of loss from ART at 6months.
RESULTS A significantly greater proportion of adults in the home group initiated ART
(181/8194, 2.2%) compared with the facility group (63/8466, 0.7%; risk ratio [RR], 2.94, 95%
CI, 2.10-4.12; P < .001). Uptake of HIV self-testing was high in both the home (5287/8194,
64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23; 95% CI, 0.96-1.58; P = .10).
Significantly more adults reported positive HIV self-test results in the home group (490/8194
[6.0%] vs the facility group, 278/8466 [3.3%]; RR, 1.86; 95% CI, 1.16-2.97; P = .006). After 6
months, 52 of 181 ART initiators (28.7%) and 15 of 63 ART initiators (23.8%) in the home and
facility groups, respectively, were lost from ART (adjusted incidence rate ratio, 1.18; 95% CI,
0.62-2.25, P = .57).
CONCLUSIONS AND RELEVANCE AmongMalawian adults offered HIV self-testing, optional
home initiation of care compared with standard HIV care resulted in a significant increase in
the proportion of adults initiating ART.
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I n 2012, an estimated 35 million individuals were infectedwith the human immunodeficiency virus (HIV).1 Antiret-roviral therapy (ART) substantially reduces the risk of on-
ward HIV transmission as well as greatly reducing morbidity
andmortality,2,3 raising hopes that highuptake of annualHIV
testing and early initiation of ART could improveHIVpreven-
tion as well as care.4,5
Achieving high coverage of HIV testing is a major chal-
lenge. Surveys in 15 sub-Saharan African countries between
2009 and 2012 show that only 20.0% of women and 20.5% of
men were tested for HIV in the previous year.6 Once tested,
individuals need to access care and prevention services to
maximize the individual and public health benefits of knowl-
edgeofHIVstatus.However,onlyone-fifthofpatients link into
care without any periods of loss to follow-up.7-9
Self-testing for HIV infection is a novel approach that is
highly acceptable in Malawi and the United States.10,11 Self-
testing forHIVhasbeendefinedas individualsperformingand
interpretingtheirHIVtest inprivate,12 aprocess thatcouldover-
comebarriers to conventional facility-based and community-
based HIV testing, which lack privacy and convenience.13,14
However, no studies in high HIV prevalence settings have in-
vestigated linkage into HIV care after HIV self-testing. Home
initiationofHIV carehasnot previously been investigated, al-
thoughhomecontinuation ofARTwasnoninferior to facility-
based services in a Ugandan trial.15
We therefore tested the hypothesis that offering optional
home initiation of HIV care after HIV self-testing might in-
crease population-level uptake of ART and increase willing-
ness to test and to report positive results compared with HIV
self-testing accompanied by facility-based services only.
Methods
This was a second-stage randomization of clusters allocated
to the HIV self-testing group of a parent study, which was a
cluster randomized trial comparing health outcomes
achieved under HIV self-testing vs standard-of-care HIV
testing (with 14 vs 14 clusters in each group of the parent
trial).16 The present study was a cluster randomized trial
using the 14 community health worker catchment areas
allocated to receive HIV self-testing in the parent trial.
These 14 clusters underwent restricted randomization into 2
groups: HIV self-testing followed by optional home initia-
tion of HIV care or HIV self-testing accompanied by facility-
based HIV care.
Participants and Study Setting
There are 26 administrativewards in Blantyre,Malawi. Three
wards (Ndirande, Likhabula, andChilomoni)were selected as
the study site. They were all located in the northwest area of
the city and comprised high-density urban neighborhoods.
Comprehensive HIV care (including ART) was only available
at 3 health facilities (Ndirande and Chilomoni Health Centres
and Queen Elizabeth Central Hospital).
Between April and June 2011, 14 of a possible 73 commu-
nity health worker catchment area clusters (5 in Ndirande,
6 in Likhabula, and 3 in Chilomoni) (Figure 1) were selected
purposely to ensure sufficient distance and separation
between cluster boundaries to reduce risk of con-
tamination.17 Clusters that were delineated by natural bound-
aries (rivers, roads, forests, etc) were preferentially selected.
Boundaries of selected clusters were defined by study
research assistants and Ministry of Health community health
workers walking the boundary of each community health
worker’s catchment area recording coordinates with global
positioning satellite receivers (eTrex Legend HCx, Garmin
International). All households within clusters were enumer-
ated by research assistants recruited from clusters, and a
sociodemographic questionnaire was performed with the
head of each household, or if unavailable, an adult household
representative.
The research ethics committees of the College of Medi-
cine, University of Malawi, Liverpool School of Tropical
Medicine, and London School of Hygiene and Tropical Medi-
cine approved the study. All participants provided written
informed consent (or a witnessed thumbprint if illiterate) for
HIV self-testing and separately for home initiation of care.
Interventions
Twovolunteercounselors fromeachcluster, selectedusingpar-
ticipatorymethods,18were trained inHIV testing. Prior toHIV
self-testing availability, counselors in all 14 clusters pro-
moted the availability ofHIV self-testing bydoor-to-door vis-
its and leafleting. Between January 30, 2012, and November
5, 2012, oralHIV test kits (OraQuickAdvanceRapidHIV-1/2 an-
tibody test, OraSure Technologies) were distributed to adult
residents requesting HIV self-testing from the counselors’
home (1 kit per resident per year), with pretest information
about HIV self-testing, counseling, and demonstration of kit
use. Participantswere asked to self-test in the privacy of their
Figure 1. Location of Study Clusters and Allocation
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ownhouseand to return theused testkit inperson to thecoun-
selor in a sealed envelope. Participants were not required to
report self-test results to the counselor; if they declined to do
so, they receivedgenericposttest counseling.Participantswho
reported self-test results received results-based counseling.
Counselors recorded numbers of HIV self-test kits distrib-
uted and positive results.
All participants who had positive results on self-testing
could self-refer or be referred by counselors to study clinics
where study nurses performed confirmatory HIV testing, tu-
berculosis (TB) screening (and provided isoniazid preventive
therapy [IPT] if eligible), World Health Organization (WHO)
staging, and CD4 cell counts; provided cotrimoxazole; and
made onward referral for ART initiation (routine ART clinics
within the same facility) if eligible (CD4 cell count <350/μL,
WHO stage 3 or 4, pregnant, or breastfeeding).19
In the 7 clusters allocated to the home group, at the same
timeduringwhichHIVself-testingwasbeingpromoted, coun-
selors additionally promoted (verbally and with leaflets) the
availability of home services during the door-to-door visits.
The counselors provided a second leaflet and verbal informa-
tiononhomeservices toparticipantswhenattending thecoun-
selor’s home to request HIV self-testing. Counselors orga-
nized homevisits by study nurses for participants reporting a
positiveHIV self-test result and requesting home initiation of
care. Nurses visited each participant twice (first visit within 3
days and second visit within 7 days) to carry out confirma-
tory HIV testing, WHO staging, CD4 cell count (venous blood
for laboratory testing), and TB screening (with IPT if eligible)
and to provide 2 weeks of ART if the participant was eligible.
Participants were provided with completed ART registration
cards and a follow-up appointment at their nearest HIV care
clinic.
Adult ART initiations during the study period were
ascertained by (1) recording home ART initiations and (2)
interviewing all adults who initiated ART at any of the 3 clin-
ics serving the study population and using printed satellite
maps marked with cluster boundaries and local landmarks,
followed if necessary by a home visit, to establish cluster
residence.20 Data from clinic registers and treatment cards
were extracted for the 6 months following ART initiation in
all identified study residents, without reference to group.
Self-reported adherence was assessed by questionnaire at 3
points after ART initiation (at 2-4 weeks, 3 months, and 6
months) using the AIDS Clinical Trials Group adherence
questionnaire.21
Outcomes
The primary outcome compared between groups was the cu-
mulative incidence of ART initiation among all adult cluster
residents (regardless of HIV status, ART eligibility, site of HIV
testing, orART initiation)during the first 6monthsofHIV self-
testingavailability.Thesecondaryoutcomescompared thecu-
mulative incidence of taking an HIV self-testing kit (regard-
less ofwhether used), reporting a positiveHIV self-test result
to counselors, and loss from ART by 6 months (with partici-
pants recorded as still taking ART or transferred out to an-
other clinic classified as retained).
Sample Size
We assumed that adult HIV prevalence was 18.5%,10 50% of
HIV-positive self-testing adults would report a positive result
to counselors, and 5% of the adult population would initiate
ARTover 6months in the facility group.Amean cluster popu-
lation of 1200 adults in 14 clusters provided 80% power at a
5% level of significance to detect a risk ratio (RR) of 1.5 be-
tween groups of the adult populationwho initiatedART,with
a coefficient of variation k = .20.17
Randomization andMasking
Clusters were randomized at a public meeting after restrict-
ing possible allocations to ensure that for each of the 3wards,
thedifference in thenumberof clustersallocated toeachgroup
wouldbenomore than2 (providing2100uniqueallocationpat-
terns). Community representativesdrewcoloredballs froman
opaque bag held above eye level to select the distribution of
clusters and group allocation. Counselors and residents were
notmasked to the intervention, but investigator blindingwas
maintained until the final analysis.
Statistical Methods and Cost Analysis
For the primary and secondary outcomes, analysis was done
by intention to treat. CONSORT guidelines were followed in
reporting preplanned study outcomes (eMethods 1 in the
Supplement).22 The cluster-level proportions of residents
who initiated ART, took an HIV self-test kit, and reported a
positive HIV self-test result in each intervention group were
compared using the t test, with the unadjusted RR calculated
as the ratio of cluster-averaged means using the method
described by Hayes andMoulton.17 The analysis was adjusted
for death reported in households in the year preceding enu-
meration. Because data on these outcomes were not linked to
individuals and were collected and analyzed at the cluster
level, there were no missing data to take into account in the
analysis.
A separate analysis was used to assess rates of loss from
ART with the denominator being adult residents who initi-
ated ART. The ART initiators whose treatment records indi-
cated that theywere still taking ART or had transferred to an-
other ART clinic were classified as retained on ART. The ART
initiatorswhose treatment records indicated that theyhaddied
or defaulted fromARTwere classified as lost toART.23NoART
initiatorshadmissingdata forARToutcome.Cluster-level rates
of loss fromART ineachgroupwere comparedusing the t test,
with theunadjusted rate ratio calculatedas the ratioof cluster-
averagedmeans andwith subsequent adjustment for sex, age,
pregnancy status, CD4 cell count strata, andWHO stage. The
3 of 244participants (1.2%) forwhomWHOstagewasmissing
were not included in this adjusted analysis. Under national
treatmentguidelines,CD4cell countwasnot indicatedforpreg-
nantwomen and individuals inWHO stage 3 or 4 andwas not
measuredprior toART initiation in facilities. Therefore, for the
69 of 244 individuals (28.3%) without CD4 cell count results,
a category for missing was constructed.
Characteristics of ART initiators were compared between
groups using χ2 tests for categorical characteristics and
Kruskal-Wallis tests for continuous characteristics. Differ-
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ences in adherence between the 2 groups were compared
using χ2 tests. Tests were 2-sided and a P value of ≤.05 was
considered significant. Stata version 12.1 (StataCorp) was
used for analysis.
A partial cost analysis was undertaken of the home ART
initiation service fromaprogrammaticperspective (eMethods
2 in the Supplement).24 The cost estimates do not include the
costs of facility-based assessment and initiation or down-
stream HIV care costs.
Results
The 14 clusters enumerated between April and June 2011 had
a combined adult population of 16 660,with 8194 adults resi-
dent in 3213 households in the home group and 8466 adults
resident in 3397 households in the facility group (Figure 2).
Characteristics were well balanced between groups (Table 1),
apart from reported household deaths in the previous year
(home group: 131/8194, 4.1%; facility group: 81/8466, 2.4%).
Primary Outcome
Between January 30, 2012, andNovember 5, 2012, 244 cluster
resident adults initiated ART during 6 months of HIV self-
testing availability. The cumulative incidence of ART initia-
tionwassignificantlyhigher in thehomegroup (181/8194, 2.2%
of residents) comparedwith the facility group (63/8466, 0.7%
of residents;RR, 2.94; 95%CI, 2.10-4.12;P < .001) (Table 2). Af-
ter adjusting for reportedhouseholdmortality at baseline, the
effect of availability of home care initiation remained statis-
tically significant (adjusted RR, 2.44; 95% CI, 1.61-3.68;
P < .001).
Of the 181 residents initiating ART in the home group, 116
(64.0%) initiated at home and 65 (36%) initiated at 1 of the 3
health facilities. Thedifference betweengroups inART initia-
tionwasmaintained throughout theanalysisperiod (Figure3).
Secondary Outcomes
During the 6 months of availability, a total of 9720 of 16 660
adult residents (58.3%) took anHIV self-test kit. Therewasno
significant difference in uptake between the home (5278/
8194, 64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23;
95%CI,0.96-1.58;P = .10).Participants in thehomegroup(490/
8194, 6.0%)were significantlymore likely to report a positive
HIV self-test result than facility group participants (278/
8466, 3.3%; RR, 1.86; 95% CI, 1.16-2.97; P = .006).
HomeART initiators had significantly highermedianCD4
cell counts compared with facility initiators (eTable 1 in the
Supplement):medianCD4cell countatARTinitiationwashigh-
est among home initiators in the home group (219/μL, inter-
quartile range [IQR], 135-305) compared with facility initia-
tors in the home group (154/μL, IQR, 116-249) and the facility
group (187/μL, IQR, 100-256; P = .04).
Loss FromARTOver 6Months
After 6 months, 52 of 181 participants (28.7%; 30/116 [25.9%]
home initiators and 22/65 [33.8%] facility initiators) who ini-
tiatedART in thehomegroupand 15of 63participants (23.8%)
in the facility group were lost from ART. Treatment records
showed that 5 of 181 (2.8%) and 1 of 63 (1.6%) ART initiators in
the home and facility groups died, respectively. In unad-
justed analysis, the rate of loss from ART was higher in ART
initiators in the home group (63.4/1000 person-months; 95%
CI, 42.7-84.1) than in the facility group (53.5/1000 person-
Figure 2. Flowchart of HIV Self-testing and ART Initiation inMalawi
28 Clusters in parent trial
14 Clusters allocated to HIV self-testing
14 Randomized
7 Clusters included in analyses
8194 Participants included in
primary analysis
0 Participants excluded from
primary analysis
181 Participants included in
secondary analysis (ART initiators)
8013 Participants excluded from
secondary analysis (did not
initiate ART)
7 Randomized to home group
8194 Participants in 7 clusters (mean
cluster size, 1179; median, 1203;
range, 923-1416)
7 Received home option as
randomized
7 Randomized to facility group
8466 Participants in 7 clusters (mean
cluster size, 1209; median, 1209;
range, 1075-1276)
7 Received facility-based treatment
as randomized
7 Clusters included in analyses
8466 Participants included in
primary analysis
0 Participants excluded from
primary analysis
63 Participants included in
secondary analysis (ART initiators)
8403 Participants excluded from
secondary analysis (did not
initiate ART)
0 Clusters discontinued intervention 0 Clusters discontinued intervention
ART indicates antiretroviral therapy.
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months; 95% CI, 23.7-83.4), although not significant (inci-
dence rate ratio [IRR], 1.18; 95% CI, 0.67-2.10). Adjusting for
risk factors had little effect (adjusted IRR, 1.18; 95% CI, 0.62-
2.25).
There were 201 ART initiators (82.4% of all ART initia-
tions and 91.0% of initiators who returned for a subsequent
clinic appointment) who completed the adherence question-
naire 2 to 4 weeks after ART initiation, 145 (59.4% of all ART
initiators and82.9%of individuals retained in care)who com-
pleted thequestionnaire at 3months, and119 (48.8%ofallART
initiators and67.2%of individuals retained in care)who com-
pletedquestionnaires at 6months.Overall, of thosewithdata
available, 19 of 164 (11.6%) and 3 of 60 (5.0%)ART initiators in
thehomeand facility groups, respectively, self-reportedmiss-
ing at least 1 dose of ART in the past 4 days at any assessment
point (P = .14).
Cost Analysis
The total cost of the home-based ART service was US
$20 005.24 (45 809.16 international dollars) (eTable 2 in the
Supplement). The average cost per participant assessed was
US $97.11 (222.37 international dollars), and the average cost
per participant who initiated ART through the home service
was US $172.46 (394.91 international dollars).
Discussion
Themainfindingof thiscluster randomizedtrialwas thatpopu-
lation-level ART initiations were significantly increased (RR,
2.94;95%CI,2.10-4.12)byavailabilityofhomeinitiationofcare.
To our knowledge, this is the first study to investigate the ef-
fects of a comprehensive home-based HIV testing, eligibility
Table 1. Baseline Characteristics
Home Group Facility Group
No. of clusters 7 7
No. of households 3213 3397
No. of adults (aged ≥16 y) 8194 8466
Cluster Characteristics
Adults per cluster, mean (range), No. 1179 (923-1416) 1209 (1075-1276)
Population density per cluster, persons per m2, mean (range) 0.016 (0.009-0.030) 0.024 (0.010-0.044)
Household Characteristics
Adults per household, mean (SD), No. 2.55 (1.26) 2.48 (1.17)
Children per household, mean (SD), No. 1.96 (1.58) 1.93 (1.54)
Household wealth quintile, No. (%)a
1 (poorest) 730 (23.3) 806 (24.3)
2 (poorer than average) 656 (21.0) 703 (21.2)
3 (average) 599 (19.2) 696 (21.0)
4 (wealthier than average) 602 (19.2) 589 (17.8)
5 (least poor) 540 (17.3) 518 (15.6)
Death in household in year preceding enumeration, No. (%) 131 (4.1) 81 (2.4)
Individual Characteristics (Adults Only)
Age, mean (SD), y 30.4 (11.8) 30.2 (11.4)
Age group, y, No. (%)
16-19 1312 (16.1) 1227 (14.5)
20-29 3312 (40.5) 3556 (42.1)
30-39 2113 (25.9) 2267 (26.8)
40-49 785 (9.6) 788 (9.3)
50-59 363 (4.4) 355 (4.2)
≥60 285 (3.5) 255 (3.0)
Male, No. (%)b 4252 (52.5) 4399 (52.6)
Marital status, No. (%)c
Married or cohabiting 5031 (62.8) 5293 (64.4)
Never married 2441 (30.5) 2403 (29.2)
Widowed, separated, or divorced 535 (6.7) 524 (6.4)
Ever lost a spouse, No. (%)d 378 (4.7) 373 (4.5)
Highest level of education, No. (%)e
No schooling 217 (2.7) 237 (2.9)
Primary 3168 (39.7) 3214 (38.7)
Secondary, no MSCE 2389 (30.0) 2863 (34.5)
Secondary with MSCE 1564 (19.6) 1465 (17.6)
Higher 635 (8.0) 520 (6.3)
Abbreviation: MSCE: Malawi
secondary certificate of education.
a Missing values: home group: 86,
facility group: 85.
bMissing values: home group: 7,
facility group: 79.
c Missing values: home group: 163,
facility group: 228.
dMissing values: home group: 180,
facility group: 224.
e Missing values: home group: 197,
facility group: 149.
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assessment, and treatment initiation strategy. The uptake of
HIV self-testing during the first 6 months of availability was
high in both groups (58% overall). At a time when universal
test and treat approaches to controlling the HIV epidemic are
being considered,4 home initiation of HIV care shows high
promise as a simple strategy to improve uptake of ART when
HIV self-testing is carried out at home.
The absolute difference between groups was 1.5%
(2.2% − 0.7%) or, assuming adult HIV prevalence was 18.5%
in both groups10 and 76% of adults eligible for ART under
2010 WHO guidelines were taking ART at baseline,1 an
additional 7.9 per 100 HIV-infected adult residents (181/
[8194 × 18.5%] − 63/[8466 × 18.5%]) and 33.0 per 100 ART-
eligible HIV-infected adults (181/[8194 × 18.5% × 24%] − (63/
[8466 × 18.5% × 24%]) initiated ART when both HIV self-
testing and home initiation of HIV care were offered
(detailed calculations in eTable 3 in the Supplement). We
attribute this increase to removal of existing barriers to ini-
tial linkage to ART, including mistrust of routine clinic-
based services and the intense pressure of time related to
extreme poverty.13,25 Reassuringly, offering the option of
home initiation of HIV care did not simply shift ART initia-
tions from health facilities to home: the rate of facility ART
initiations was maintained between groups, while home ini-
tiations provided extra numbers.
AlthoughHIVself-testinghasbeenavailable formore than
20 years,26 it has only recently been considered for use in na-
tionalHIV testingprograms.27FollowingUSFoodandDrugAd-
ministration approval for over-the-counter sale of anoralHIV
self-test kit in 2012,28 and 2 pilot studies from Kenya29 and
Malawi10showinghighacceptabilityanduptake, therehasbeen
Figure 3. Cluster Resident ART Initiations During 6Months
of HIV Self-testing Availability
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Table 2. Primary and Secondary Trial End Pointsa
Home Group Facility Group
Risk or Rate
Ratio
(95% CI) P Value k0
No./Total
No.
% or Rate per 1000
Person-Months
(95% CI)
No./Total
No.
% or Rate per 1000
Person-Months
(95% CI)
Primary trial outcome:
ART initiations
Unadjustedb 181/8194c 2.2% 63/8466 0.7% 2.94 (2.10-4.12) <.001 .15
Adjusted 2.44 (1.61-3.68) <.001
Secondary trial
outcomes
HIV self-tests 5287/8194 64.9% 4433/8466 52.7% 1.23 (0.96-1.58) .10 .23
Reporting of HIV
positive self-test
results
490/8194 6.0% 278/8466 3.3% 1.86 (1.16-2.97) .006 .50
Loss from ART if
initiated ART
Unadjusted 52/181 63.4 (42.7-84.1) 15/63 53.5 (23.7-83.4) 1.18 (0.67-2.10) .52
Adjusted 1.18 (0.62-2.25) .57
Abbreviations: ART, antiretroviral therapy; k0, intracluster coefficient of
variation in facility group; WHO,World Health Organization.
a For ART initiation, HIV self-tests, and reporting of positive HIV self-test results,
denominators are total number of adult residents. For loss from ART,
denominator is all adult cluster residents who initiated ART (regardless of site
of HIV testing, or site of ART initiation) during first 6months of HIV self-testing
availability. Unadjusted proportions of adult residents initiating ART, taking
HIV self-testing kits, and reporting positive HIV self-testing results were
compared using the t test with the risk ratio calculated as the ratio of
cluster-averagedmeans. Ninety-five percent CIs were calculated based on the
t distribution and using a Taylor approximation to estimate the standard error
of the log risk ratio. The analysis was adjusted for reported household death in
the previous year using a logistic regressionmodel to estimate cluster-specific
predicted prevalence of the outcome (risk residuals), which were compared
using the t test with the risk ratio calculated as the ratio of cluster-averaged
risk residuals. For this adjusted analysis, 95% CIs and P values were calculated
from the cluster-specific residuals based on the t distribution and using a
Taylor approximation to estimate the standard error of the log risk ratio.
Unadjusted rates of loss from ART among ART initiators were compared using
the t test, with the rate ratio calculated as the ratio of cluster-averagedmeans.
The analysis was adjusted for sex, age, pregnancy status, WHO clinical stage
(1/2 or 3/4), and CD4 cell count strata (>350/μL, 201-350/μL,200/μL, or
missing [n = 69]) at ART initiation using a Poisson regressionmodel to
estimate cluster-specific prevalence of covariates (rate residuals), which were
compared using the t test with the rate ratio calculated as the ratio of
cluster-averaged rate residuals. For this adjusted analysis, 95% CIs and
P values were calculated from the cluster-specific residuals based on the
t distribution and using a Taylor approximation to estimate the standard error
of the log rate ratio. Three individuals who hadmissing data for WHO clinical
stage were excluded from this adjusted analysis.
b Includes all ART initiations among cluster resident adults during the first 6
months of HIV self-testing availability, regardless of site of ART initiation
(home or facility).
c Of the 181 residents initiating ART in the home group, 116 (64.0%) initiated at
home and 65 (36%) initiated at 1 of the 3 health facilities.
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renewed interest in HIV self-testing as a strategy for comple-
mentingexistingHIVtestingservices.27AdvantagesofHIVself-
testing include increasedconvenienceandconfidentialitycom-
pared with facility-based HIV testing.10
Economic analysis found the cost of homeassessmentper
participant tobeUS$97.11 (222.37 internationaldollars) and the
cost per individual initiatedwithART tobeUS $172.46 (394.91
international dollars). This compares favorablywith commu-
nity-based HIV testing programs (US $7.77-$126.48 per indi-
vidual tested)11 and the annual costs of providing ART in fa-
cilities (US $857.84-$1165.47).30 Patient costs were not
considered in this analysis. However, home initiation of care
will likely have savings for individuals who would otherwise
incur substantial transport and opportunity costs. The costs
of the HIV self-testing service, costs of facility-based initia-
tion of care, and the differences in downstreammanagement
costs were not considered. The home-based service identi-
fiedparticipantsat significantlyhighermedianCD4cell counts,
which will likely affect cost-effectiveness through prolonged
survival,31 reduced early HIV management costs,32 and in-
creased lifetime HIV treatment costs.
Loss fromARTover6monthswasworse in thehomegroup
than in the facility group, although the differences were not
statistically significant, andoverall numbers of initiatorswere
small, limitingpower to identify anythingother than largedif-
ferences. Pooled across study groups, 72.5% of ART initiators
were still taking ART at 6 months. This is below national HIV
program estimates for Malawi (80% retained at 12months33),
although still within the range seen in other programs.34 The
study setting, with recruitment from urban slums, may have
led to inclusion of a greater proportion of highlymobile indi-
viduals compared with other areas of the country. The trend
toward poorer outcomes among ART initiators in the home
group means that careful monitoring and treatment support
should be provided for home ART initiators in future studies
to avoid losing the initial populationbenefits of homeART ini-
tiation.
Perceived lackof confidentiality (whichcouldbemorepro-
nounced in smaller or rural communities) has been cited as a
potential barrier to uptake when HIV interventions are of-
fered in the home, although in a previous trial of home con-
tinuationofARTafter facility initiation, dropoutdue to stigma
wasextremelyuncommon.15Weovercame thesepotential dif-
ficulties by developing a partnership with the community
(through volunteer counselors and community representa-
tive groups) and with participants by giving pretest informa-
tionabout thepotential advantagesanddisadvantagesofhome
initiation of HIV care. Regular meetings were held with com-
munity stakeholders where concerns could be raised and ad-
dressed. No incentives (financial or otherwise) were pro-
vided to participants or providers.
Limitations of the study include the need to use all adult
cluster residents (not people living with HIV or ART-eligible
adults) as our denominator. This reflects the lack of available
cluster-level HIV prevalence and CD4 cell count data. How-
ever, ART initiation remained statistically significantly
increased in the home group after adjusting for household
mortality in the previous year, which could have been
indicative of differences in HIV prevalence or ART coverage
between study groups. To maintain privacy and confidenti-
ality, individual HIV self-testing participants were not fol-
lowed up as a cohort; reporting results was optional and not
required. Therefore, we cannot estimate overall linkage into
care after positive HIV self-testing or examine any given step
of the HIV care pathway. Total numbers of ART initiations
were small, meaning that larger studies are required to fully
evaluate the possible trends toward worse retention of ART
in the home initiation group. Initiators of ART were followed
up for only a short period (6 months) and default from ART
was not followed up by active tracing. Clinical outcomes of
ART initiators (including causes of death) were not assessed
at 6 months. Because HIV self-testing was implemented
through neighborhood volunteers living close to partici-
pants, home initiation of HIV care was a highly feasible
option in this situation andmay not apply to other models of
HIV self-testing delivery. Other models for encouraging link-
age may need to be developed and ideally directly compared
for effectiveness.
Conclusions
Among Malawian adults offered HIV self-testing, optional
home initiation of care compared with standard HIV care re-
sulted in a significant increase in the proportion of adults ini-
tiating ART.
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